Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Harvard Business School
Fuji
Dow
Mallinckrodt
Merck
Boehringer Ingelheim
US Army
Cerilliant
Moodys

Generated: January 23, 2018

DrugPatentWatch Database Preview

ATRACURIUM BESYLATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for atracurium besylate and what is the scope of atracurium besylate patent protection?

Atracurium besylate
is the generic ingredient in four branded drugs marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hospira, Hospira Inc, Mylan Labs Ltd, Nanjing King-friend, Teva Parenteral, Watson Pharms Teva, West-ward Pharms Int, and Watson Labs Inc, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for atracurium besylate. Five suppliers are listed for this compound.
Pharmacology for ATRACURIUM BESYLATE
Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE

US Patents and Regulatory Information for ATRACURIUM BESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074900-001 Jul 18, 1997 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074632-001 Dec 23, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074824-001 Sep 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 090761-001 Oct 18, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 206096-001 Jun 22, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074944-001 Jul 28, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare Corp ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074768-001 Jan 23, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira Inc ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 090782-001 Oct 18, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074741-001 Mar 28, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074740-001 Mar 28, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Express Scripts
Baxter
Healthtrust
US Department of Justice
Daiichi Sankyo
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot